- Home
- IZM vs LSB Comparison
IZM vs LSB Comparison
Compare IZM & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- LSB
- Stock Information
- Founded
- IZM 2011
- LSB 2002
- Country
- IZM China
- LSB China
- Employees
- IZM N/A
- LSB N/A
- Industry
- IZM Consumer Electronics/Video Chains
- LSB
- Sector
- IZM Consumer Discretionary
- LSB
- Exchange
- IZM Nasdaq
- LSB NYSE
- Market Cap
- IZM 21.1M
- LSB 22.3M
- IPO Year
- IZM 2023
- LSB N/A
- Fundamental
- Price
- IZM $2.39
- LSB $1.00
- Analyst Decision
- IZM
- LSB
- Analyst Count
- IZM 0
- LSB 0
- Target Price
- IZM N/A
- LSB N/A
- AVG Volume (30 Days)
- IZM 28.8K
- LSB 14.1K
- Earning Date
- IZM 07-25-2025
- LSB 06-21-2025
- Dividend Yield
- IZM N/A
- LSB N/A
- EPS Growth
- IZM N/A
- LSB N/A
- EPS
- IZM N/A
- LSB N/A
- Revenue
- IZM $177,933,890.00
- LSB $79,415,311.00
- Revenue This Year
- IZM N/A
- LSB $39.33
- Revenue Next Year
- IZM N/A
- LSB $75.61
- P/E Ratio
- IZM N/A
- LSB N/A
- Revenue Growth
- IZM N/A
- LSB N/A
- 52 Week Low
- IZM $1.18
- LSB $0.36
- 52 Week High
- IZM $3.19
- LSB $6.82
- Technical
- Relative Strength Index (RSI)
- IZM 58.47
- LSB 30.24
- Support Level
- IZM $2.28
- LSB $0.91
- Resistance Level
- IZM $2.42
- LSB $1.09
- Average True Range (ATR)
- IZM 0.11
- LSB 0.06
- MACD
- IZM -0.03
- LSB 0.02
- Stochastic Oscillator
- IZM 45.45
- LSB 29.03
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.